中文別名:Z-7-[1R,2R,3R,5S-3,5-二羥基-2-[E,3S-3-羥基-5-苯基戊-1-烯基]環(huán)戊基]-N-乙基庚-5-烯酰胺

英文別名:N-ETHYL-9ALPHA,11ALPHA,15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE; LUMIGAN; BIMATOPROSTTM; 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE; BIMATOPROSTLUMIGAN; 17-phenyl-tri-norprostaglandin f2α-ethyl amide; Z-7-[1R,2R,3R,5S-3,5-Dihydroxy-2-[E,3S-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide; 5Z-7-{1R,2R,3R,5S-3,5-dihydroxy-2-[1E,3S-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide; 5E-7-{1R,2R,3R,5S-3,5-dihydroxy-2-[1E,3S-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide

CAS:155206-00-1

EINECS:-

相對密度:1.145g/cm3

比馬前列素被認為是目前降IOP作用最強的局部抗青光眼藥物對正常人POAG和OHT患者均有效主要用于不能耐受其他降IOP藥或使用其他降IOP藥物無效的POAG或OHT患者